Angel Biotechnology reported a pre-tax loss of almost £1.1m in 2008 as revenues rose 8% to £952,926. The company sees better prospects for 2009 and 2010 as it has recently signed three major contracts, with a value of £2.2m and its prospective new business pipeline is the best it has seen to date.
RTT News
Thursday, 11 June 2009
Angel reduces losses, sees positive future
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment